https://www.ajmc.com/view/fda-approves-benralizumab-for-eosinophilic-granulomatosis-with-polyangiitis
The FDA approved benralizumab (Fasenra) for adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
fdabenralizumabeosinophilicgranulomatosispolyangiitis